Found: 13
Select item for more details and to access through your institution.
Synthesis of a dual carbon‐14‐labeled calcitonin gene‐related peptide receptor antagonist for use in a human absorption–distribution–metabolism–elimination study.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 5, p. 126, doi. 10.1002/jlcr.3966
- By:
- Publication type:
- Article
Synthesis of carbon‐14 and stable isotope labeled Censavudine.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 4, p. 112, doi. 10.1002/jlcr.3964
- By:
- Publication type:
- Article
Synthesis of tritium labeled 30‐KDa PEG and conjugation to form [<sup>3</sup>H]Pegbelfermin.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2021, v. 64, n. 12, p. 477, doi. 10.1002/jlcr.3940
- By:
- Publication type:
- Article
Synthesis of isotopically labeled daclatasvir for use in human clinical studies.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 4, p. 164, doi. 10.1002/jlcr.3386
- By:
- Publication type:
- Article
Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2015, v. 58, n. 9, p. 361, doi. 10.1002/jlcr.3312
- By:
- Publication type:
- Article
Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 10, p. 600, doi. 10.1002/jlcr.3224
- By:
- Publication type:
- Article
An alternative and robust synthesis of [<sup>13</sup>C<sub>4</sub>]Baraclude® (entecavir).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2013, v. 56, n. 12, p. 632, doi. 10.1002/jlcr.3064
- By:
- Publication type:
- Article
Synthesis of [D<sub>4</sub>]- and [D<sub>7</sub>]-4 β-hydroxycholesterols for use in a novel drug-drug interaction assay.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 2, p. 61, doi. 10.1002/jlcr.1952
- By:
- Publication type:
- Article
Synthesis and stability of a carbon-14-labeled 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2011, v. 54, n. 2, p. 72, doi. 10.1002/jlcr.1810
- By:
- Publication type:
- Article
Carbon-14 labeled methyl 2-chloro-2-oxoacetate: a convenient carbon-14 labeled oxalyl chloride equivalent.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 13, p. 549, doi. 10.1002/jlcr.1673
- By:
- Publication type:
- Article
Synthesis of carbon-14 labelled midazolam.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 10, p. 419, doi. 10.1002/jlcr.1620
- By:
- Publication type:
- Article
Synthesis of the anxiolytic agent [<sup>14</sup>C] 6-hydroxy-buspirone for use in a human ADME study.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2007, v. 50, n. 2, p. 65, doi. 10.1002/jlcr.1148
- By:
- Publication type:
- Article
Synthesis of <sup>13</sup>C<sub>6</sub>-labeled Reyataz™ (BMS-232632).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2005, v. 48, n. 2, p. 123, doi. 10.1002/jlcr.905
- By:
- Publication type:
- Article